N66S (p.Asn66Ser) variant of PCDH19 (Protocadherin-19)

N66S (p.Asn66Ser) in PCDH19 (Protocadherin-19) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Developmental and epileptic encephalopathy, 9. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

N66S (p.Asn66Ser) variant details